[The comparative study of lymph node dissection by video-assisted thoracoscopic surgery (VATS) and conventional lateral incision surgery].

Qiang Li, Jintao He, Xiang Zhuang, Xiao‐Jun Yang, Jiang Zhu, Tianpeng Xie, Ping Xiao, Xiang Wang, Hao RongPubMed 2010 · DOI

TL;DR

This study compares video-assisted thoracoscopic surgery (VATS) with traditional open surgery for peripheral lung cancer, focusing on lymph node dissection. The findings suggest VATS is as effective as open surgery in removing lymph nodes and achieving radical resection, offering a less invasive option for patients.

What Problem Does This Paper Address?

The paper addresses a persistent debate in thoracic surgery regarding the efficacy of minimally invasive techniques for treating lung cancer. While VATS has gained traction for its reduced invasiveness, some surgeons remain skeptical about its ability to achieve the same thoroughness in lymph node dissection as conventional open thoracotomy. This is crucial because adequate lymph node dissection is a cornerstone of radical lung cancer surgery, directly impacting patient prognosis. The study aims to provide comparative data on lymph node clearance between VATS and traditional open surgery for peripheral lung cancer, specifically addressing the concern that VATS might compromise oncological outcomes due to limited exposure.

Methods

The study employed a prospective, randomized controlled trial design. One hundred patients diagnosed with peripheral non-small cell lung cancer were randomly assigned to either the VATS group or the conventional posterolateral incision surgery group, with 50 patients in each.

  • VATS Group: Patients underwent VATS-assisted radical resection and lymph node dissection. This involved a small incision (approximately 4-5 cm) for specimen retrieval and lymph node dissection, with a thoracoscope used for visualization.
  • Conventional Surgery Group: Patients underwent standard posterolateral incision radical resection and lymph node dissection.

The primary outcome measures were the total number of lymph nodes removed and the number of positive lymph nodes identified in both groups. Statistical analysis was performed using the chi-squared test (χ²) with a significance level of P < 0.05.

Datasets

The study utilized data from 100 patients treated at Sichuan Cancer Hospital between January 2007 and December 2009. These patients were selected based on specific inclusion criteria:

  • Preoperative diagnosis of non-small cell lung cancer (or intraoperative frozen section diagnosis).
  • Peripheral lung cancer confined to one hemithorax, with no distant metastasis.
  • Clinical stage up to IIIA, or incidental N2 disease.
  • No extensive pleural adhesions.
  • Performance status score > 80.
  • Single tumor lesion.

The study did not introduce any new datasets or benchmarks; it relied on the clinical data of its patient cohort.

Key Insights and Ideas

  • VATS is not just for benign conditions: The study directly challenges the notion that VATS is only suitable for benign thoracic diseases, demonstrating its efficacy in radical lung cancer surgery.
  • Lymph node dissection equivalence: The core insight is that VATS can achieve a comparable extent and quality of lymph node dissection as traditional open surgery, dispelling concerns about compromised oncological principles.
  • Minimally invasive benefits: While not the primary focus of the comparison, the paper implicitly highlights the advantages of VATS in terms of reduced trauma, pain, and faster recovery, making it a more patient-friendly option.
  • Potential for wider adoption: The findings suggest that VATS is a viable and effective option for selected lung cancer patients, advocating for its broader implementation in hospitals with the necessary resources and expertise.

Key Results

The study found no statistically significant difference between the VATS and conventional surgery groups in terms of lymph node dissection:

  • Total Lymph Nodes Removed:
    • VATS group: N1 (242), N2 (232), N3 (0)
    • Conventional group: N1 (243), N2 (238), N3 (1)
    • Total lymph nodes: No significant difference (χ²=0.016, P=0.815).
  • Positive Lymph Nodes:
    • VATS group: 197 positive lymph nodes.
  • Conventional group: 198 positive lymph nodes.
  • Positive lymph nodes: No significant difference (χ²=0.034, P=0.956).

Limitations and Future Work

  • Patient Selection: The study focused on peripheral lung cancer. The authors acknowledge that VATS might not be suitable for all lung cancer cases, particularly those with central tumors or extensive nodal involvement.
  • Sample Size: While 100 patients is a reasonable sample size for this type of comparative study, larger multi-center trials could further strengthen the findings and explore long-term oncological outcomes.
  • Surgeon Experience: The success of VATS is highly dependent on surgeon experience. The paper implies that with accumulated experience, VATS can achieve thorough dissection, but this learning curve is an inherent factor.
  • Future Work: The authors suggest that VATS is a promising approach for selected lung cancer patients and should be promoted in hospitals with the necessary infrastructure and expertise. Further research could explore long-term survival rates, recurrence patterns, and quality of life comparisons between VATS and open surgery for lung cancer.

Summary updated

Abstract

peripheral lung cancer may get radical resection and lymph node clearance by VATS. There are no significant difference for the number of removed lymph nodes and positive rate of lymph nodes in VATS and conventional surgery.
BibTeX
@inproceedings{li2010comparative,
  author = {Qiang Li and Jintao He and Xiang Zhuang and Xiao‐Jun Yang and Jiang Zhu and Tianpeng Xie and Ping Xiao and Xiang Wang and Hao Rong},
  title = {{[The comparative study of lymph node dissection by video-assisted thoracoscopic surgery (VATS) and conventional lateral incision surgery].}},
  booktitle = {PubMed},
  year = {2010},
  doi = {10.3779/j.issn.1009-3419.2010.12.18},
}
Figure